|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 601 13th St., NW |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20005-2000 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 46676-12
|
||||||||
|
6. House ID# 395790000
|
TYPE OF REPORT | 8. Year | 2025 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: AMY E. MODLIN |
Date | 7/18/2025 11:46:45 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues:
Affordable Care Act (ACA), ACA subsidies and tax credits; Telehealth/ telehealth flexibilities; ACA Fraud; Transparency in coverage; Surprise Billing; 2025 Proposed NBPP/Individual Market/ACA exchanges; Rural healthcare; Prior Authorization; Hospital Consolidation; Employer-provided health coverage; Cyber Attack/ Cyber Security; Provider Directories; Health Equity + Maternal Health; Hospital Billing; Anti-tiering, Anti-steering; Health Equity; Program integrity in the individual marketplace; Federal Budget Process; Artificial Intelligence
Bills:
S.1869 - SITE Act
To amend title XVIII of the Social Security Act and title XXVII of the Public Health Service Act to ensure fair billing practice for items and services furnished by off-campus hospital locations, to amend such title XVIII to provide for payments for graduate nursing education costs, and for other purposes.
Sponsor: Sen. Braun, Mike [R-IN]
H.R.3417 - FAIR Act
To ensure fair billing practices for items and services furnished by off-campus outpatient departments of a provider.
Sponsor: Rep. Hern, Kevin [R-OK-1]
H.R. 5378 Lower Costs, More Transparency Act
To promote price transparency in the health care sector, and for other purposes.
Sponsor: Rep. McMorris Rodgers, Cathy [R-WA-5]
H.R.2483 - Support for Patients and Communities Reauthorization Act
To reauthorize certain programs that provide for opioid use disorder prevention, treatment, and recovery, and for other purposes.
Sponsor: Rep. Guthrie, Brett [R-KY-2]
S.3393 - SUPPORT for Patients and Communities Reauthorization Act
To reauthorize the SUPPORT for Patients and Communities Act, and for other purposes.
Sponsor: Sen. Sanders, Bernard [I-VT]
S.2016 - CONNECT for Health Act of 2023
To amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes.
Sponsor: Sen. Schatz, Brian [D-HI]
H.R. 4189, CONNECT for Health Act
To amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes.
Sponsor: Rep. Thompson, Mike [D-CA-4]
H.R. 6033, SPEAK Act
To require the Secretary of Health and Human Services to establish a task force to improve access to health care information technology for non-English speakers.
Sponsor: Rep. Steel, Michelle [R-CA-45]
H.R. 10545, American Relief Act, 2025
Making further continuing appropriations for the fiscal year ending September 30, 2025, and for other purposes.
Sponsor: Rep. Cole, Tom [R-OK-4]
H.R. 1627 TREATS Act
To amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment, and for other purposes.
Sponsor: Rep. Norcross, Donald [D-NJ-1]
H.R.1909 - Preventing Maternal Deaths Reauthorization Act of 2025
To amend the Public Health Service Act to reauthorize support for State-based maternal mortality review committees, to direct the Secretary of Health and Human Services to disseminate best practices on maternal mortality prevention to hospitals, State-based professional societies, and perinatal quality collaboratives, and for other purposes.
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1]
S.46 - Health Care Affordability Act of 2025
A bill to amend the Internal Revenue Code of 1986 to expand eligibility for the refundable credit for coverage under a qualified health plan.
Sponsor: Sen. Shaheen, Jeanne [D-NH]
H.R.247 - Health Care Affordability Act of 2025
To amend the Internal Revenue Code of 1986 to expand eligibility for the refundable credit for coverage under a qualified health plan.
Sponsor: Rep. Underwood, Lauren [D-IL-14]
H.R.3237
To amend title XVIII of the Social Security Act to require each off-campus outpatient department of a provider to include a unique identifier on claims for items and services, and to require providers with a department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each such department.
Sponsor: Rep. Joyce, John [R-PA-13]
H.R.3312 - Moms Matter Act
This bill establishes two grant programs to address maternal mental health conditions and substance use disorders, with a focus on demographic groups with elevated rates of maternal mortality and morbidity, maternal health disparities, and other adverse outcomes.
Sponsor: Rep. Blunt Rochester, Lisa [D-DE-At Large]
H.R.3029 - Primary Care Enhancement Act of 2023
To amend the Internal Revenue Code of 1986 to allow individuals with direct primary care service arrangements to remain eligible individuals for purposes of health savings accounts, and for other purposes.
Sponsor: Rep. Smucker, Lloyd [R-PA-11]
S.5535 - No Surprises Act Enforcement Act
To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to increase penalties for group health plans and health insurance issuers for practices that violate balance billing requirements, and for other purposes.
Sponsor: Sen. Marshall, Roger [R-KS]
S.1973 - Treat and Reduce Obesity Act of 2025
To amend title XVIII of the Social Security Act to provide for the coordination of programs to prevent and treat obesity, and for other purposes.
Sponsor: Sen. Cassidy, Bill [R-LA]
H.R.2571 - Self-Insurance Protection Act
To amend the Employee Retirement Income Security Act of 1974 to exclude from the definition of health insurance coverage certain medical stop-loss insurance obtained by certain plan sponsors of group health plans, and for other purposes.
Sponsor: Rep. Onder, Robert [R-MO-3]
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Modlin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues:
Site neutral payment reform; Health Equity Index reward factor; Health Equity Index for MA plans; Value Base Care; MA Reform
Bills:
H.R.5746 - Addressing Whole Health in Medicare Advantage Act
To amend title XVIII of the Social Security Act to expand the availability of supplemental benefits to certain Medicare Advantage enrollees.
Sponsor: Rep. Bilirakis, Gus M. [R-FL-12]
H.R. 7623, Telehealth Modernization Act
To amend title XVIII of the Social Security Act to make permanent certain telehealth flexibilities under the Medicare program.
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1]
H.R.1 - One Big Beautiful Bill Act
This bill reduces taxes, reduces or increases spending for various federal programs, increases the statutory debt limit, and otherwise addresses agencies and programs throughout the federal government.
Sponsor: Rep. Arrington, Jodey C. [R-TX-19]
S.1105 - No UPCODE Act
To amend title XVIII of the Social Security Act to improve risk adjustment under Medicare Advantage.
Sponsor: Sen. Cassidy, Bill [R-LA]
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Modlin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Bills:
S. 1114, Expanding Access to Low-Cost Generics Act
To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period.
Sponsor: Sen. Smith, Tina [D-MN]
S.1339 - Pharmacy Benefit Manager Reform Act
To provide for increased oversight of entities that provide pharmacy benefit management services on behalf of group health plans and health insurance coverage.
Sponsor: Sen. Sanders, Bernard [I-VT]
S. 775, Increasing Transparency in Generic Drug Applications
To provide for increased transparency in generic drug applications.
Sponsor: Sen. Hassan, Margaret Wood [D-NH]
H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Sponsor: Rep. Dunn, Neal P. [R-FL-2]
S.1542, DRUG Act
To improve services provided by pharmacy benefit managers.
Sponsor: Sen. Marshall, Roger [R-KS]
S. 1067, Ensuring Timely Access to Generics Act
To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions.
Sponsor: Sen. Shaheen, Jeanne [D-NH]
S.1041 - Affordable Prescriptions for Patients Act
A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes.
Sponsor: Sen. Cornyn, John [R-TX]
S.1096 - Preserve Access to Affordable Generics and Biosimilars Act
A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products.
Sponsor: Sen. Klobuchar, Amy [D-MN]
H.R.5429 - Medication Affordability and Patent Integrity Act
To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office.
Sponsor: Rep. Kuster, Ann M. [D-NH-2]
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Modlin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |